Long read

A ‘brand’ new approach to intellectual asset mapping at Spotify

An updated framework allows for renewed understanding of the way that a broad array of potential brand assets can drive value for knowledge companies

23 November 2022

Your guide to synthetic drug royalty dealmaking

Selling revenue streams is an increasingly important way of monetising pharma innovations

16 November 2022

Here’s how to get attorney fee awards in US patent litigation

A seminal US Supreme Court ruling did not result in a flood of fee awards, but lower courts have hashed out some requirements to secure payment.

09 November 2022

Successfully navigating ‘commercially reasonable effort’ obligations in IP agreements

Tips on winning in the courtroom plus case law and compliance guidance

02 November 2022

Why English litigation will retain a crucial strategic role in the era of the UPC

Though the UK will not be part of the new pan-EU system, it will contain to play a vital role in European litigation

26 October 2022

Exploring third-party claims in pharmaceutical patent cases

What are the rights of public healthcare providers and companies seeking damages in the United Kingdom, the Netherlands, France and Norway?

19 October 2022

Building institutional excellence: how your IP team can become ‘beloved’ by R&D

Often, a company’s IP and R&D units find themselves at odds, which can have serious knock-on impacts on how they work together to generate value

12 October 2022

Your guide to the UPC on day one

The fast-approaching opening of the court looks set to reshape the European patent litigation landscape but uncertainty still surrounds a number of jurisdictional and procedural issues

05 October 2022

The IP-backed finance and litigation funding markets revolution

Insurance policy types are proliferating and the increased certainty is attracting new lenders – a virtuous circle that looks set to cut capital costs for IP-rich companies

28 September 2022

Samsung settles NPE 5G suit; Avanci licensee surge; Top EPO and PCT firms named; The US’s most litigious operating companies; Elon Musk’s patent peril; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

25 September 2022

How the America Invents Act has hurt SMEs

As the legislation celebrates 10 years, Michael Renaud, Jonathan Engler and Jessica Perry of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo analyse a decade of data to reveal that, far from helping small businesses by improving patent quality, it has only succeeded in driving them out of US district courts.

21 September 2022

Meet 2022’s IP Hall of Fame inductees

Following a selection process that ran between March and May, IAM announced that four new individuals had been chosen to join the IP Hall of Fame in 2022: Pravin Anand, Justice Stephen Breyer, Louis Foreman and James Malackowski. They were officially inducted at this year’s IPBC Global in June.

14 September 2022

Why the United States urgently needs patent subject-matter eligibility reform

The law is in a state of disarray that has led to inconsistent case decisions, deep uncertainty in the innovative, investment and legal communities, and unpredictable outcomes in prosecution and litigation. David Kappos, Paul Michel, Corey Salsberg and Matthew Dowd argue that the United States' legislators must act to ensure the country maintains its long-standing competitive edge in the global innovation race

07 September 2022

How the UPC will change the global patent litigation landscape

This time next year, the new EU system is almost certain to be up and running. For rights holders and potential defendants, it will mean rethinking long-established strategic choices and preparing for a new set of major challenges. Gwilym Roberts, David Rose and Suzanne Harrison explain why 'game changing' may not be too hyperbolic a way to describe what is approaching

31 August 2022

The contribution patents make to enterprise value

No commonly used valuation methods are much help at putting a number on an entire portfolio unless there is a specific transaction on the horizon. Cipher’s Nigel Swycher and Steve Harris suggest an original methodology to fill this gap

03 August 2022

Optimising the integration of AI and human intelligence – lessons for tomorrow’s IP practice

While a new generation of tools promise to facilitate the creation of high-value assets, Benedikt Biechele, Brendan Sever and Bruce Rubinger warn that integrating them with professionals’ subject-matter expertise remains a major challenge

27 July 2022

Building incentives to overcome the SEP licensing prisoner’s dilemma

Patent pools can provide long-term mutual benefits for many industries, especially those based on FRAND-enabled technology standards. But for them to succeed, write Bowman Heiden and Gustav Brismark, short-term buy and sell-side misalignments must be overcome. The recently announced Sisvel WiFi 6 Pool may provide some answers

20 July 2022

The top takeaways from IPBC Global 2022

After a month of reflection following the successful event in Chicago, which was attended by 600 delegates, IAM reporters pick out the biggest stories that emerged from the three days

13 July 2022

How patents facilitate market entry and promote competition

It may seem like unconventional wisdom to some, but it is more important than ever to challenge the belief that strong IP protection discourages innovation and hinders choice, argues Jonathan M Barnett

06 July 2022

Why it's time to create transparency around 5G SEPs

Shared perspective among industry participants will stimulate greater understanding of the cellular market environment and increase confidence and accuracy in IP executive decision-making, write Bowman Heiden and Lew Zeretzki

29 June 2022

Unlock unlimited access to all IAM content